Market Tracker

04/26 5:15pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

18.85
Delayed Data
As of 4:00pm ET
 +0.20 / +1.07%
Today’s Change
5.15
Today|||52-Week Range
24.45
+0.80%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close18.65
Today’s open18.85
Day’s range18.75 - 19.33
Volume1,030,783
Average volume (3 months)1,514,863
Market cap$1.1B
Data as of 4:00pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+38.01%
Earnings growth (this year)+5.94%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.04%
P/E ratioNM
Price/Sales3,008.76
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+0.09+0.32%
XNCRXencor Inc+0.06+0.20%
DERMDermira Inc+0.01+0.11%
AIMTAimmune Therapeutics...+0.71+2.30%
Data as of 4:00pm ET, 04/26/2018

Financials

Next reporting dateMay 7, 2018
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$327.0K
Annual profit (last year)-$95.2M
Net profit margin-29,099.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts